Implications of PBMs including their own biosimilars on formularies CVS Caremark and Express Scripps are including their own biosimilars on their formularies, while also excluding others' biosimilars. This has strategic implications impacting various industry participants and patients. #biotech #biotechnology #biopharma #pharmaceuticalindustry #R&D #research & development #innovation #life cycle management #investment #VC #Venturecapital #capitalmarkets #privateequity #financing #IRA #Inflation Reduction Act #FTC #Orange Book #Price #Market Access
Fascinating article, Molly!
Life Sciences and Healthcare IT Strategy Executive
2moMolly Hoult - great analysis! I found myself thinking about point #6 even before I flipped to the next page. In my mind, #6 will compound pressure on regulators coming from the Change Healthcare incident and the overall sense that some large players have become too big, increased systemic risk, and increased costs without improving outcomes.